Home › GLP-1 Medications › Novo Nordisk › Ozempic
Latest four-week snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each assistant brings the brand up in recommendation answers.
| assistant | share of voice | answers |
|---|---|---|
| ChatGPT | 79% | 19 of 24 |
| Claude | 96% | 23 of 24 |
| Gemini | 50% | 12 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 75% | 54 of 72 |
Recurring descriptions in the assistants' own words, grouped by theme.
“Additionally, weekly injections are more convenient than Victoza's daily regimen, and both manufacturers offer copay saving cards that can dramatically lower your out-of-pocket costs.”
“Choose **Ozempic** if your primary goal is managing Type 2 Diabetes or protecting your heart If you have Type 2 diabetes, **Ozempic** is the correct choice.”
“If Your Goal is Managing Type 2 Diabetes: Choose **Ozempic**”
“However, Rybelsus was also approved for cardiovascular risk reduction in adults with type 2 diabetes.”
“* **The Ozempic Routine:** Ozempic is a once-weekly injection.”
“Mounjaro is a first-of-its-kind **dual GIP and GLP-1 receptor agonist**.”
“* **Ozempic** is specifically FDA-approved to lower blood sugar in adults with type 2 diabetes and to reduce the risk of major cardiovascular events (like stroke or heart attack) in diabetics with established heart disease.”
“your insurance might not cover Victoza, but it might cover **Ozempic (semaglutide)** or **Trulicity (dulaglutide)** with a much lower monthly copay.”
“Both are semaglutide GLP-1 medicines, and both carry similar core risks.”
“Ozempic contains the same active ingredient (semaglutide) but is primarily approved for **type 2 diabetes** and related cardiovascular/kidney-risk indications.”
237 exact quoted mentions in this snapshot, grouped by coded tone.
“Widely used, effective for blood sugar control and weight loss”
“These undergo formal FDA review for safety and efficacy, so their approved labeling and core efficacy claims are backed by clinical trial data.”
“FDA-approved manufacturers (Novo Nordisk's Ozempic/Wegovy, Eli Lilly's Mounjaro/Zepbound)”
“FDA-approved brand-name drugs (Ozempic, Wegovy, Mounjaro, Zepbound) These went through rigorous clinical trials and FDA review, so their core efficacy/safety data is credible.”
“CMS is providing eligible Medicare beneficiaries access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, 2027, as part of a demonstration program. This covers injectable Mounjaro, Ozempic, and Zepb”
“**Ozempic** – FDA-approved for type 2 diabetes (often prescribed off-label for weight loss)”
“**Ozempic** (semaglutide)”
“**Ozempic** – approved for type 2 diabetes, sometimes prescribed off-label for weight loss”
“**Semaglutide** – sold as Ozempic (diabetes) and Wegovy (weight loss); also an oral version, Rybelsus”
“**Ozempic** (semaglutide) – weekly injection”
“Novo Nordisk (maker of Ozempic and Wegovy) has been hit with **multiple FDA warning letters in 2026** for misleading TV ads.”
“**Do not choose Ozempic or Mounjaro solely because they are popular.** They contain the same active ingredients as Wegovy and Zepbound, respectively, but are branded and FDA-approved primarily for type 2 diabetes”
“Do **not** simply substitute Ozempic/Mounjaro for Wegovy/Zepbound on your own.”
“Avoid compounded "semaglutide" or "tirzepatide," research peptides, and products claiming to be generic Ozempic/Wegovy/Mounjaro/Zepbound.”
“Do not buy Ozempic or Mounjaro "for weight loss" on your own; they are branded for diabetes, while **Wegovy and Zepbound** are the FDA-approved brands specifically for chronic weight management.”
Which competitors assistants suggest when shoppers ask for something cheaper.
35 of 237 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|---|
| eden.health | 3 |
| buzzrx.com | 3 |
| primetherapeutics.com | 2 |
| noom.com | 2 |
| plexusdx.com | 2 |
| healthline.com | 2 |
| drugwatch.com | 2 |
| singlecare.com | 2 |
| prescriberpoint.com | 1 |
| cochrane.org | 1 |
| everydayhealth.com | 1 |
| fda.gov | 1 |
Stores and sites assistants name as places to buy this brand.
| retailer | mentions |
|---|---|
| NovoCare | 3 |
| GoodRx | 2 |
| Publix | 1 |
| Publix Pharmacy | 1 |
| NovoCare Pharmacy | 1 |
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.